| DAVITA INC. DL -,001 |
| USA |
| Gesundheit |
| US23918K1088 / 897914 |
| TRL (Frankfurt) / DVA (NYSE) |
| FRA:TRL, ETR:TRL, TRL:GR, NYSE:DVA |
| S&P500 |
| https://www.davita.com/ |
|
DaVita Inc. is a healthcare services company focused on kidney care, with its core business centered on outpatient dialysis for patients living with chronic kidney disease and end-stage renal disease. DaVita provides in-center hemodialysis, peritonea..
>Volltext.. |
| 10737.83 Mio. EUR |
| 23395.19 Mio. EUR |
| 12465.04 Mio. EUR |
| 2492.19 Mio. EUR |
| 731.8 Mio. EUR |
| 10.78 EUR |
| 11928.37 Mio. EUR |
| 668.96 Mio. EUR |
| 1951.51 Mio. EUR |
| 0.27 |
| 9.79% |
| 1.44% |
| - |
| - |
| - |
| - |
| DAVITA |
| 20.10.26 |
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|
||||
|